2,3 GLP-1 Receptor Agonists: A Critical Look at the Evidence Two GLP-1 receptor agonists, semaglutide and liraglutide (Saxenda), are approved by the US Food and Drug Administration for treating obesity in adolescents 12 years and older with a BMI at the 95th percentile or higher
Comparison of the efficacy of glucagon-like peptide-1 receptor agonists in patients with metabolic associated fatty liver disease: Updated systematic review and meta-analysis
Your provider can help you plan the transition carefully, avoiding high-stress times like the holidays, and prepare strategies to manage the return of food cravings and "food noise" that often resurface when the medication is stopped
Rev Med Suisse 19:756760 Armamento-Villareal R, Aguirre L, Waters DL, Napoli N, Qualls C, Villareal DT (2020) Effect of aerobic or resistance exercise, or both, on bone mineral density and bone metabolism in obese older adults while dieting: a randomized controlled trial
Selenium studies show that selenium increases glutathione peroxidase levels
Pretty easy right